Research Article
A Prognostic Model Based on Six Metabolism-Related Genes in Colorectal Cancer
Table 6
The ten representative KEGG pathways in high- and low-risk groups.
| Names | Size | ES | NES | NOM -value | FDR -value |
| High-risk group | KEGG_complement_and_coagulation_cascades | 69 | 0.684 | 2.100 | 0.002 | 0.030 | KEGG_basal_cell_carcinoma | 55 | 0.620 | 2.077 | 0.002 | 0.022 | KEGG_glycosaminoglycan_biosynthesis_chondroitin_sulfate | 22 | 0.795 | 2.048 | 0 | 0.021 | KEGG_ECM_receptor_interaction | 84 | 0.708 | 2.021 | 0.006 | 0.022 | KEGG_autoimmune_thyroid_disease | 50 | 0.724 | 2.018 | 0.002 | 0.018 | Low-risk group | KEGG_propanoate_metabolism | 32 | −0.842 | −2.357 | 0 | 0 | KEGG_peroxisome | 78 | −0.725 | −2.328 | 0 | 0 | KEGG_fatty_acid_metabolism | 42 | −0.776 | −2.302 | 0 | 4.22-04 | KEGG_valine_leucine_and_isoleucine_degradation | 43 | −0.816 | −2.249 | 0 | 3.71-04 | KEGG_butanoate_metabolism | 34 | −0.764 | −2.147 | 0 | 0.003 |
|
|